Escrito por estudiantes que aprobaron Inmediatamente disponible después del pago Leer en línea o como PDF ¿Documento equivocado? Cámbialo gratis 4,6 TrustPilot
logo-home
Document preview thumbnail
Vista previa 4 fuera de 63 páginas
Examen

Biotechnology Comprehensive Practice Examination (2026–2027 Edition): Advanced Biotechnology, Molecular Biology, Genetic Engineering, CRISPR, Synthetic Biology, Bioprocess Engineering, Bioinformatics, Genomics, Immunotechnology & Biopharmaceutical Manufac

Document preview thumbnail
Vista previa 4 fuera de 63 páginas

Advance your knowledge of modern biotechnology with the Biotechnology Comprehensive Practice Examination (2026–2027 Edition). Developed for biotechnology students, graduate researchers, laboratory scientists, biomedical professionals, pharmaceutical specialists, and certification candidates, this comprehensive practice examination features 100 high-difficulty multiple-choice questions designed to assess advanced theoretical knowledge, laboratory applications, and biotechnology industry practices. Updated for the 2026–2027 academic and professional standards, this examination reflects the latest developments in molecular biology, genome engineering, synthetic biology, biopharmaceutical manufacturing, computational biology, and laboratory quality management. Each question includes a verified answer with a detailed rationale, helping learners strengthen scientific understanding while developing the analytical and problem-solving skills required in university examinations and biotechnology careers.

Vista previa del contenido

Biotechnology Comprehensive Practice
Examination (2026–2027 Edition)
Advanced Biotechnology Certification &
University Examination Preparation |
High-Difficulty Multiple-Choice Questions
| Molecular Biology • Genetic Engineering
• CRISPR • Synthetic Biology • Bioprocess
Engineering • Bioinformatics •
Immunotechnology • Genomics • Cell
Culture • Biopharmaceutical
Manufacturing • Laboratory Quality
Systems • Verified Answers with Detailed
Rationales


Question 1
A researcher is attempting to maximize expression of a
recombinant human protein in Escherichia coli. Although

,transcription is high, protein yield remains extremely low.
Ribosome profiling indicates poor translation initiation. Which
modification is most likely to improve protein production
without altering promoter activity?
A. Increase plasmid copy number
B. Replace the Shine–Dalgarno sequence with an optimized
ribosome-binding site
C. Insert additional transcription terminators
D. Increase genomic GC content
Answer: B
Rationale: Translation initiation in bacteria depends heavily on
an efficient ribosome-binding (Shine–Dalgarno) sequence.
Optimizing this region enhances ribosome recruitment and
protein synthesis without affecting transcription.



Question 2
Which DNA polymerase possesses the highest proofreading
fidelity and is therefore preferred for cloning applications
requiring minimal mutation rates?
A. Taq DNA Polymerase
B. Terminal deoxynucleotidyl transferase
C. Pfu DNA Polymerase

,D. Reverse Transcriptase
Answer: C
Rationale: Pfu DNA polymerase exhibits 3′→5′ exonuclease
proofreading activity, producing substantially fewer replication
errors than Taq polymerase.



Question 3
A CRISPR-Cas9 experiment aims to introduce a precise point
mutation rather than create a gene knockout. Which cellular
DNA repair mechanism must predominate for successful
editing?
A. Base excision repair
B. Mismatch repair
C. Homology-directed repair (HDR)
D. Non-homologous end joining (NHEJ)
Answer: C
Rationale: Precise sequence replacement requires homology-
directed repair using a donor DNA template, whereas NHEJ
typically generates insertions or deletions.



Question 4

, Which sequencing technology is capable of directly detecting
DNA methylation without requiring bisulfite conversion?
A. Sanger sequencing
B. Illumina sequencing
C. Oxford Nanopore sequencing
D. AFLP analysis
Answer: C
Rationale: Nanopore sequencing measures changes in electrical
current as nucleic acids pass through a pore, allowing direct
identification of modified bases such as methylated cytosines.



Question 5
A recombinant antibody exhibits aggregation during
downstream purification. Which strategy is most likely to reduce
aggregation while preserving biological activity?
A. Increase purification temperature
B. Lower solution pH to extreme acidic values
C. Optimize buffer composition and include stabilizing
excipients
D. Eliminate all purification steps
Answer: C

Información del documento

Subido en
20 de julio de 2026
Número de páginas
63
Escrito en
2025/2026
Tipo
Examen
Contiene
Preguntas y respuestas
$24.49

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Vendido
0
Seguidores
0
Artículos
416
Última venta
-


Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes